The participation of TNF-TNFRs in cancer and inflammatory diseases is well-documented, and TNF-therapies directed to control their activity have been developed, but improved therapies are needed to be more effective and avoid undesirable side effects6,7. The gene discussed is TNF; the disease is cancer.